Drug deaths are down in one Ohio county and much of the US
UC College of Nursing professor discusses the impact of fentanyl
The Washington Post recently published a story discussing Hamilton County’s successes in battling the opioid crisis. That journey in many ways parallels the nation’s experience at the start of 2025.
The Post reports that drug deaths fueled primarily by illicit fentanyl reached staggering heights by 2023, topping 100,000 for the third straight year. But in the 12-month period ending in August, deaths had decreased by more than 20 percent from the same period the previous year, according to provisional state data published by the Centers for Disease Control and Prevention. Although the CDC won’t publish 2024 estimates for several months, experts say there could be more than 20,000 fewer deaths than the year before.
The newspaper spoke with families who lost loved ones and others who survived opioid addiction along with first-responders and community agencies that were among the first line of defense. Tasha Turner-Bicknell, an associate professor of nursing at UC, and a board member of Harm Reduction Ohio also weighed in on the discussion and spoke with the Post. Harm Reduction Ohio supplies free naloxone to a network of distributors on the streets.
Tasha Turner-Bicknell, associate professor at the UC College of Nursing
“I would add that these numbers are encouraging and demonstrate that harm reduction saves lives,” says Turner-Bicknell, who is also director of advanced public health nursing DNP and certificate programs at UC. “We still have a lot of work to do. We need to continue to strengthen and expand harm reduction programs to meet people where they are and offer them the support services they need.”
The Post reports that government officials, researchers and public health organizations have puzzled over the reasons but speculate a decline in deaths represents a confluence of factors that vary regionally. The Biden administration made Narcan, a nasal spray version of the overdose-reversal medication naloxone, available without a prescription and broadened access to medications to treat opioid addiction. Officials touted crackdowns on Mexican criminal groups that manufacture fentanyl and Chinese companies that supply them with chemicals needed to make the opioid.
Read the full story in The Washington Post online.
Learn more about Tasha Turner-Bicknell online.
Related Stories
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.
UC Board of Trustees approves $12 million for building design phase for new welcome gateway
March 13, 2026
The UC Board of Trustees approved $12 million at its Feb. 24 meeting for the design phase of a new Welcome Gateway Building for Uptown campus.
Dual-arm robot stabilizes satellite for repairs in space
March 13, 2026
Interesting Engineering highlights an aerospace engineering research project examining novel ways to keep repair robots oriented in space.